Lactate-induced epithelial-mesenchymal transition: a metabolic nexus in pancreatic cancer metastasis
Translational Cancer Research · 2026-08 · 15 (8) · 657-657
DOI: 10.21037/tcr-2026-0806 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Cancer Research, 2026-08. Verfasst von Jiachen Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical School, Guilin Medical University, Guilin, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Lactate-driven epithelial-mesenchymal transition (EMT) constitutes a pivotal metabolic hub in pancreatic ductal adenocarcinoma (PDAC). PDAC is a highly lethal malignancy characterized by early metastasis, pronounced chemotherapy resistance, and poor prognosis, in which epithelial-mesenchymal plasticity (EMP) acts as the core mechanism driving malignant progression. Metabolic reprogramming represented by the Warburg effect leads to massive lactate accumulation in PDAC. Lactate is no longer regarded as an inert metabolic end product, but serves as a critical energy substrate, signaling molecule, and epigenetic modifier that mediates histone lactylation. This review systematically elaborates the unique characteristics of lactate metabolism in PDAC, including efficient lactate production driven by oncogenic mutations and hypoxic microenvironment, transmembrane transport via monocarboxylate transporters (MCTs), intracellular metabolic fate, and protein lactylation modification. It further summarizes the core mechanisms by which lactate metabolism regulates EMP, including direct regulation through lactate itself and lactylation modification, activation of signaling pathways such as TGF-β, GSK-3β, and YAP/TAZ-Hedgehog, as well as remodeling of tumor microenvironment (TME) involving cancer-associated fibroblasts (CAFs) and immune cells. Finally, therapeutic strategies targeting the lactate metabolism-EMP axis are discussed, covering inhibition of lactate production and transport, precise intervention of lactylation modification, and neutralization of TME acidification, aiming to provide novel theoretical basis and intervention targets for overcoming metastasis and chemotherapy resistance in PDAC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical Medical School, Guilin Medical University, Guilin, China.
- Department of Medicine, Guangxi University of Science and Technology, Liuzhou, China.
ORCID-Profile: Zhengyi Xie
Zitieren
APA
Yang, J., Pang, Y., & Xie, Z. (2026). Lactate-induced epithelial-mesenchymal transition: a metabolic nexus in pancreatic cancer metastasis. Translational Cancer Research, 15(8), 657-657. https://doi.org/10.21037/tcr-2026-0806
Vancouver
Yang J, Pang Y, Xie Z. Lactate-induced epithelial-mesenchymal transition: a metabolic nexus in pancreatic cancer metastasis. Translational Cancer Research. 2026;15(8):657-657. doi:10.21037/tcr-2026-0806
BibTeX
@article{Yang2026,
author = {Yang, Jiachen and Pang, Yonghui and Xie, Zhengyi},
title = {Lactate-induced epithelial-mesenchymal transition: a metabolic nexus in pancreatic cancer metastasis},
journal = {Translational Cancer Research},
year = {2026},
volume = {15},
number = {8},
pages = {657--657},
doi = {10.21037/tcr-2026-0806}
}
EUVIMED